AstraZeneca PLC is 388.7x more valuable than Inventiva S.A. by market capitalization ($286.27 B vs $736.43 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IVA | AZN |
|---|---|---|
| Market cap | $736.43 M | $286.27 B |
| US-listed rank | #2667 | #45 |
| SEC filings | 211 | 1,004 |
AstraZeneca PLC is 388.7x more valuable than Inventiva S.A. by market capitalization ($286.27 B vs $736.43 M).
Full pages: Inventiva S.A. and AstraZeneca PLC, or browse the full rankings.